An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825 Article

Gittleman, Haley, Lim, Daniel, Kattan, Michael W et al. (2017). An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825 . NEURO-ONCOLOGY, 19(5), 669-677. 10.1093/neuonc/now208

Open Access International Collaboration

cited authors

  • Gittleman, Haley; Lim, Daniel; Kattan, Michael W; Chakravarti, Arnab; Gilbert, Mark R; Lassman, Andrew B; Lo, Simon S; Machtay, Mitchell; Sloan, Andrew E; Sulman, Erik P; Tian, Devin; Vogelbaum, Michael A; Wang, Tony JC; Penas-Prado, Marta; Youssef, Emad; Blumenthal, Deborah T; Zhang, Peixin; Mehta, Minesh P; Barnholtz-Sloan, Jill S

sustainable development goals

authors

publication date

  • May 1, 2017

published in

keywords

  • ADJUVANT TEMOZOLOMIDE
  • BRAIN
  • CONCOMITANT
  • Clinical Neurology
  • EORTC
  • Life Sciences & Biomedicine
  • MULTIFORME
  • NRG Oncology
  • Neurosciences & Neurology
  • Oncology
  • PROGNOSIS
  • PROMOTER METHYLATION
  • RADIOTHERAPY
  • RANDOMIZED PHASE-III
  • RTOG
  • Science & Technology
  • TRIAL
  • glioblastoma
  • nomogram
  • survival

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 669

end page

  • 677

volume

  • 19

issue

  • 5